Lipid Management Utilizing PCSK9 Inhibitors

Deepak R. Talreja, MD, discusses the current advances in lipidology. Here he discusses lipid management that utilizes PCSK9 inhibitors, how these effect cholesterol, how to determine if your patient is a candidate for this type of treatment, and what complications one might expect from this treatment. 


February 16, 2018

Created by


Related Presenters

Deepak Talreja, M.D.

Deepak Talreja, MD

Cardiology, Internal Medicine

Board Certifications American Board of Internal Medicine - Cardiovascular Disease American Board of Internal Medicine - Internal Medicine American Board of Internal Medicine - Interventional Cardiology Gender Male Medical ...

View full profile